EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A practical inflammatory blood-cell marker for cardiovascular risk stratification in psoriasis: Development of the Platelet-Leukocyte Adjusted Cardiovascular (PLAC) score

Julian A Cortes, Shaliz Aflatooni, Andrea Ure, Gabriela Palma, Nicole Johnsen, Kimberly Smart iD, Yvonne Nong, April W Armstrong iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0353475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Julian A Cortes und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of California, San Diego, School of Medicine, San Diego, California, United States of America. Hauptthemen laut MEDLINE: Psoriasis, Blood Platelets, Cardiovascular Diseases, Leukocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psoriasis is an inflammatory disease associated with atherosclerotic cardiovascular disease (ASCVD). Although blood-cell markers predict ASCVD in the general population, the utility of these markers in cardiovascular risk stratification in psoriasis remains unclear given heightened inflammatory burdens among these patients.

Objectives

We aimed to develop a composite ASCVD risk score for psoriasis and evaluate its performance by integrating a novel inflammatory blood-cell marker with traditional cardiovascular risk factors.

Methods

We conducted a retrospective cohort study using All of Us (enrollment:May 2018-October 2023). ASCVD included acute coronary syndrome, cerebrovascular accident, or coronary artery disease. Independent predictors of ASCVD in Cox regression informed the Platelet-Leukocyte Adjusted Cardiovascular (PLAC) score, incorporating the Neutrophil-to-Platelet-to-Monocyte Ratio (NuPMoR=neutrophils/[platelets x monocytes]), age ≥ 65, male sex, hypertension, and diabetes.

Results

Among 1,572 psoriasis patients (median follow-up 7.2 years), the PLAC score (AUC 0.69, 95% CI 0.65–0.74), which incorporates NuPMoR, stratified patients into low-, medium-, and high-risk groups with corresponding 10-year ASCVD incidences of 4.9%, 11.8%, and 39.9%. Compared with the low-risk group, medium- (HR 2.27, 95% CI 1.53–3.39) and high-risk (HR 6.40, 95% CI 3.97–10.33) groups had significantly higher ASCVD hazard. The PLAC score demonstrated similar or numerically higher discrimination than the Framingham and PCE models in limited samples.

Conclusions

The PLAC score is a practical, psoriasis-specific ASCVD risk tool that integrates a novel inflammatory marker with traditional risk factors. It enables clinically meaningful ASCVD risk stratification using routine laboratory values in a high-risk population and may help identify psoriasis patients warranting closer cardiovascular monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisBlood PlateletsCardiovascular DiseasesLeukocytesHumansMaleFemaleRetrospective StudiesBiomarkersMiddle AgedAgedInflammationRisk AssessmentHeart Disease Risk FactorsRisk FactorsNeutrophils

Substanzen

Biomarkers

Autor:innen und Institutionen

  • University of California, San Diego, School of Medicine, San Diego, California, United States of America.
  • University of South Florida Morsani College of Medicine, Tampa, Florida, United States of America.
  • University of California, Davis School of Medicine, Sacramento, California, United States of America.
  • Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, Uniondale, New York, United States of America.
  • David Geffen School of Medicine at the University of California, Los Angeles, California, United States of America.
  • Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.

ORCID-Profile: Kimberly Smart, April W Armstrong

Zitieren

APA

Cortes, J. A., Aflatooni, S., Ure, A., Palma, G., Johnsen, N., Smart, K., Nong, Y., & Armstrong, A. W. (2026). A practical inflammatory blood-cell marker for cardiovascular risk stratification in psoriasis: Development of the Platelet-Leukocyte Adjusted Cardiovascular (PLAC) score. PLOS One. https://doi.org/10.1371/journal.pone.0353475

Vancouver

Cortes JA, Aflatooni S, Ure A, Palma G, Johnsen N, Smart K, et al. A practical inflammatory blood-cell marker for cardiovascular risk stratification in psoriasis: Development of the Platelet-Leukocyte Adjusted Cardiovascular (PLAC) score. PLOS One. 2026. doi:10.1371/journal.pone.0353475

BibTeX
@article{Cortes2026,
  author = {Cortes, Julian A and Aflatooni, Shaliz and Ure, Andrea and Palma, Gabriela and Johnsen, Nicole and Smart, Kimberly and Nong, Yvonne and Armstrong, April W},
  title = {A practical inflammatory blood-cell marker for cardiovascular risk stratification in psoriasis: Development of the Platelet-Leukocyte Adjusted Cardiovascular (PLAC) score},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0353475}
}
Kostenlos starten →